ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $137 | -89.6% | 22,691 | -86.7% | 0.00% | -80.0% |
| Q2 2023 | $1,322 | +77.7% | 170,488 | +30.5% | 0.01% | +66.7% |
| Q1 2023 | $744 | -1.1% | 130,655 | +2.2% | 0.00% | -25.0% |
| Q4 2022 | $752 | -99.8% | 127,851 | 0.0% | 0.00% | +100.0% |
| Q3 2022 | $408,000 | -20.2% | 127,851 | +11.9% | 0.00% | -33.3% |
| Q2 2022 | $511,000 | +1662.1% | 114,216 | +1974.0% | 0.00% | – |
| Q1 2022 | $29,000 | – | 5,507 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 4,768,181 | $116,820,000 | 11.19% |
| Memorial Sloan Kettering Cancer Center | 602,272 | $14,756,000 | 9.10% |
| Euclidean Capital LLC | 996,734 | $24,420,000 | 8.17% |
| Invus Financial Advisors, LLC | 1,007,575 | $24,686,000 | 5.66% |
| EcoR1 Capital, LLC | 3,092,218 | $75,759,000 | 3.36% |
| Ally Bridge Group (NY) LLC | 413,061 | $10,120,000 | 1.94% |
| EMERALD ADVISERS, LLC | 615,511 | $15,080,000 | 0.54% |
| Orbimed Advisors | 2,337,574 | $57,271,000 | 0.54% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 624,210 | $15,293,000 | 0.51% |
| Casdin Capital, LLC | 601,515 | $14,737,000 | 0.44% |